Literature DB >> 26935754

Apoptosis is induced by shikonin through the mitochondrial signaling pathway.

Xuxia Tang1, Chen Zhang1, Jiongzhou Wei1, Yuting Fang1, Rongxiang Zhao1, Jianxin Yu2.   

Abstract

The aim of the present study was to investigate the effects of shikonin (SHI) on the induction of apoptosis in human TT medullary thyroid carcinoma cells, and to explore the role of mitochondrial signaling in this process. MTT, Annexin V‑phycoerythrin/7‑aminoactinomycin D staining, electron microscopy and JC‑1 probe staining were performed to analyze mitochondrial membrane potential, and western blot analysis was used to examine the activation of the mitochondrial signaling pathway, and the changes in mitochondrial apoptosis pathway‑associated protein expression. Following culture for 24‑72 h, treatment with various concentrations of SHI inhibited the proliferation of TT cells, in a dose‑ and time‑dependent manner. Transmission electron microscopy demonstrated the presence of typical apoptotic structures, as well as mitochondrial structural changes. The expression levels of apoptosis‑associated proteins caspase‑9, caspase‑3 and poly adenosine triphosphate ribose polymerase increased in a dose‑dependent manner following treatment with SHI. In addition, the mitochondrial membrane potential of the experimental group was significantly decreased, and the mitochondrial apoptosis pathway‑associated proteins were altered. A possible mechanism underlying SHI‑induced apoptosis through the mitochondrial signaling pathway is the regulation of B cell lymphoma 2 (Bcl‑2)/Bcl‑2‑associated protein X expression levels, resulting in the decrease in mitochondrial membrane potential and the activation of the caspase‑9/caspase‑3 enzyme‑associated reactions.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26935754     DOI: 10.3892/mmr.2016.4967

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

1.  Shikonin induces necroptosis by reactive oxygen species activation in nasopharyngeal carcinoma cell line CNE-2Z.

Authors:  Zixuan Zhang; Zhirui Zhang; Qixiang Li; Hao Jiao; Dianlong Chong; Xiaojin Sun; Pei Zhang; Qiang Huo; Hao Liu
Journal:  J Bioenerg Biomembr       Date:  2017-05-25       Impact factor: 2.945

2.  Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment.

Authors:  Qiang Wang; Jing Wang; Jiayou Wang; Xiaoli Ju; Heng Zhang
Journal:  Toxicol Res (Camb)       Date:  2021-11-26       Impact factor: 3.524

Review 3.  Antifungal Compounds against Candida Infections from Traditional Chinese Medicine.

Authors:  Xin Liu; Zhiming Ma; Jingxiao Zhang; Longfei Yang
Journal:  Biomed Res Int       Date:  2017-12-28       Impact factor: 3.411

4.  Anti-tumor effects of shikonin derivatives on human medullary thyroid carcinoma cells.

Authors:  Carina Hasenoehrl; Gert Schwach; Nassim Ghaffari-Tabrizi-Wizsy; Robert Fuchs; Nadine Kretschmer; Rudolf Bauer; Roswitha Pfragner
Journal:  Endocr Connect       Date:  2017-01-09       Impact factor: 3.335

5.  Shikonin induces mitochondria-mediated apoptosis and attenuates epithelial-mesenchymal transition in cisplatin-resistant human ovarian cancer cells.

Authors:  Kristina Shilnikova; Mei Jing Piao; Kyoung Ah Kang; Yea Seong Ryu; Jeong Eon Park; Yu Jae Hyun; Ao Xuan Zhen; Yong Joo Jeong; Uhee Jung; In Gyu Kim; Jin Won Hyun
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.